28parameters 5 Part Diff Auto Blood Hematology Cell Count Analyzer

Name: 28parameters 5 Part Diff Auto Blood Hematology Cell Count Analyzer
Brand: Zhengzhou Hepo International Trading Co., Ltd.
SKU: 716913122

Henan, ChinaZhengzhou Hepo International Trading Co., Ltd.

US$6,100.00-6,900.00

1 Piece

Sample price:US$6350.00/piece.Request sample

Product profile

Customization

Available

Classification

Biochemical Apparatus

Type

Urine Analyzer

Model NO.

HP-HEMA7000

Certification

CE, MSDS, ISO13485

Group

Middle-aged and Old

Parameters

28 Parameters+3 Histograms+1 Scattergram

Sample Volume

Whole Blood:50UL or Capillary Blood:20UL

Mearsuring Principle

Wbc Diff.: Optical Light Scatter+Impedance

Storage

More Than 5000 Results Including Histograms

Bar Code Scanning

Optional to Set

Monitor Screen

Digital Display

Auto Hematology Reagents

Diluent, Detergent, Lyse, Baso-Lyse, Eo-Lyse

Cell Dying

More Stable and Harmonious

Connect System

Lis or His System Is Ok

Assay Items

Wbc 5 Part Diff

Interface

USB, PS/2 and COM

Sampleing with Pierce Function

Optional to Set

Auto Sampling Structure

Optional to Set

Transport Package

Stregnth Carton or Plywood Package

Specification

60Tests/Hour

Trademark

HEPOBIO

Origin

China

HS Code

902780

Production Capacity

2000 Sets Per Month

Company profile

Zhengzhou Hepo International Trading Co., Ltd.

Henan, China

Business Type: Manufacturer/Factory, Trading Company, Group CorporationAverage Response Time: ≤1.54h

AI-Powered supplier vetting

SummaryThe supplier presents established manufacturing and quality-system credentials, with eight production lines, stated output across five medical-equipment categories, broad export coverage, and ISO 13485, ISO 9001, ISO 14001, and GMP certifications. It offers extensive product customization and maintains inventory capability, with stated lead times within 15 working days in both peak and off-season periods. However, evidence also shows material gaps: no written corrective-action or complaint-handling procedures, no documented service-assessment procedure, no environmental impact assessment report, no overseas warehouse or showroom, no recent new-product activity, no ODM or major-brand OEM service, no SDK, zero stated R&D patents, and no available R&D design-control documentation. Financial records are indicated for multiple years, but the slices do not provide sufficient non-financial evidence to assess financial credibility.

Supplier typeThe supplier manufactures medical and biosafety-related equipment, including cold-chain, clinical, first-aid, and laboratory products. It operates eight production lines, describes imported production equipment, and exports to multiple global regions, indicating a manufacturer with broad product and market coverage.

CertificationsThe supplier states that its factories adopted ISO 9001:2008 and ISO 13485 systems, while its supplier-management certifications include ISO 13485, ISO 9001, ISO 14001, and GMP. These explicitly stated certifications support a positive assessment of formal quality and management-system coverage.

R&D capabilityThe supplier has 11–20 years of total R&D-engineer experience and can customize products, but reports no new products during the past year, no SDK, no software-instrument R&D, zero R&D patents, and no available design-input, output, review, verification, or validation documentation. The explicit evidence indicates limited demonstrated innovation infrastructure.

Production capacityThe supplier operates eight production lines and reports production quantities for deep freezers, analyzers, and incubators, alongside inventory capability and broad export markets. Its company description also cites dedicated product solutions and imported production equipment, providing explicit evidence of substantial manufacturing capability.

Customization capabilityThe supplier explicitly offers customization from samples and designs, full, minor, and flexible customization, and assigns R&D engineers to customize products according to customer needs. However, the absence of documented R&D design-control records means process formalization is not demonstrated, while the customization offering itself is clearly supported.